In the context of neoplastic diseases, in particular pancreatic cancers, it is reasonable to assume that BSDL, which forms an equimolar complex with ApoB100 in low density lipoprotein (LDL) [30], can be captured by cancer cells via the over-expressed LDL receptor [187]. This evidence concerns the gene CEL and familial pancreatic carcinoma.